1. An opportunity for ontario
@TOHealthToronto
tohealth.ca
An opportunity for ontario

2. Life science sector is an economic driver for ontario
From LSO Life Science Sector Report 2015

3. Growing commitment from all levels of government
Municipal
Refocusing on regional economic development with formation of Newco
Municipalities hiring Life Science Sector officers
Provincial
Ontario Health Innovation Council (OHIC) report and recommendations refocus Ontario on economic development in the health sector (Dec 2014)
MRI support for the BIO International Convention Toronto Bid for 2019
Federal
Independent Panel on Federal support to Research and Development (Jenkins report) recommends a transition to applied research (2014)
Advisory Panel on Healthcare Innovation (Naylor report) recommends a systematic funding to improve innovation and adoption of improvements to the healthcare system in Canada (July 2015)

4. Toronto region is at the centre of economic growth for the sector
Sanofi Pasteur expanded manufacturing capability (2011)
$180 million invested, 1200 people employed
Roche Global Pharmaceutical Development Site (2013)
$190 million invested, 160 jobs created
Ipsen Biopharmaceuticals opens headquarters in Canada (2015)
40 jobs created
Biolab (Brazil) to expand operations internationally (2015)
$40M investment over next two years
Direct involvement of TO Health! in this program
to take residence in MaRS and be North America’s largest J&J center for incubation of start-ups

5. TO Health! is a resource to intensify and build on momentum
We are a promotion cooperative focused on raising the profile of the Toronto region human health & sciences cluster.

6. About TO health!
Vision Together we will make the Toronto region globally renowned for its dynamic and innovative human health & sciences ecosystem, placed in the top five of global human health & science clusters. Mission We will increase revenue growth opportunities for the Toronto region by attracting more risk capital, corporate investment and qualified talent to the cluster participants. 🔍
Briefing Document

7. Accomplishments to date
Activity Details
Date
Defined HHS cluster vision, mission and goals
HHS committee, with consultation and input from stakeholders in the cluster
2014
Brand identity and visuals were created
TOHealth! logo, look and feel created by KHJ, approved by committee
March 2015
Social media presence created
221 followers to date, daily interactions and building momentum
May 2015
Soft launch of TOHealth prior to HealthKick May 6th, 2015
Gave the participants in the cluster the first look at the branding, stated the Vision and Mission and call to action: ~150 people attended, Elaine Campbell, Jan De Sliva, Stefan Larson, Paul Lepage presented
May 6th, 2015
TO Health being called upon for speaking engagements in the community
LSO breakfast May 2015; MaRS Healthcare vertical May 2015; Shift Health Lunch and Learn
May/June 2015
Participated in pitch to Biolab (Brazil) with Invest Toronto, MaRS.
Company has decided to invest and locate in Toronto region ($40M investment
June 2015
Participated in Bio 2015, part of the Ontario pavilion, alongside LSO, City of Toronto, City of Mississauga, BioteCanada; Over 50 meetings with potential sponsors, brand ambassadors.
Intimately involved in BIO 2019 Toronto bid, alongside LSO, MRI, industry leaders
Provided materials, HHS committee members present to be ambassadors of the cluster/region
August 26th, 2015

8. Toronto region is the only growing metro region in north America
The region welcomes about 100,000 new residents every year. Canada’s skills-based immigration system ensures many are highly skilled
53%
13%
22%
27%
29%
Source: Statistics Canada (Toronto & Montreal Census Metropolitan Areas) and US Census (US Metropolitan Statistical Areas) for US Cities, 1991 for Canadian Cities

9. Toronto region: A global Cluster
Toronto region has a solid foundation for dynamic growth.
We have the scale and scope to place among the world’s top human health science clusters.
Source: Jones, Lang, LaSalle. Life Sciences Cluster Report 2014
Briefing Document

10. Toronto Region human health + sciences cluster
North
Downtown
“High Tech Capital”
100 ICT companies
1 university, 3 colleges
Multinational generic, digital and medical device companies
Neutraceutical and manufacturing operations
“Discovery district”
9 research hospitals, 10 community hospitals
3 universities, 3 colleges, 37 research institutes
160 biotechnology and medical device companies
east
West
“Advanced manufacturing”
Multinational generics and digital companies
Laboratories, manufacturing and warehousing operations
1 university campus, 3 hospitals
“Pill Hill”
30 multinational pharma and medical device companies
30+ small and medium biotechnology and medical device companies
Laboratories, manufacturing and warehousing operations
1 university campus, 1 college, 6 hospitals
Briefing Document

11. Global clinical trials World-leading Academic & Translational research
Perfect mix of science, business and lifestyle in the only growing metro region
A centre for
Global clinical trials
World-leading Academic
& Translational research
Briefing Document

12. World-leading Academic & Translational research
Globally recognized research universities
Over $1B in research funding at universities and partner hospitals
University of Toronto is the #2 university for publications and citations
9300+ life science graduates annually

13. World-leading Academic & Translational research
Toronto region Hospitals: a Driving Force for research
$840.5 million in research revenue
over 9500 researchers and research staff
277 IP disclosures and 73 commercializations
Source: 2013/14 metrics from CAHO CRF/RIM database

14. Toronto Region areas of expertise/Assets
THERAPEUTIC AREA EXPERTISE
CANCER
NEUROSCIENCE
CHRONIC DISEASES
Cellular and Regenerative Medicine
Genomics
Imaging and Medical Devices
Digital and Informatics
TECHNOLOGY VEHICLE EXPERTISE

15. A centre for Global clinical trials
Toronto Region is the place for Global Clinical Trials
Lower clinical trial management costs than in the U.S.
Improved approval speed and further cost reductions, thanks to a recent move to a single ethics review for multi- centre clinical trials
Data compiled from
For more information, contact Clinical Trials Ontario -

16. Advanced business environment
Lower Cost of doing business
Source: Competitive Alternatives, KPMG’s Guide to International Business Location Costs Edition
Canada has a cost advantage compared to U.S. The 3 major U.S. health sciences clusters are above the U.S. baseline for costs of doing business (Boston, NY, SF)
Source: KPMG. Competitive Alternatives: 2014 Edition. Pp

17. Advanced business environment
Access to Generous Tax Incentive Program
The Scientific Research and Experimental Development Tax Incentive Program (SR&ED) provides investment tax credits to individuals or corporations that conduct research and development in Canada
35% of eligible expenses
Refundable on the first $3M of SR&ED expenses
Taxable income and taxable capital thresholds to be maintained for refund-ability
Provincial refund ability
20% of eligible expenses
40% refund ability on SR&ED expenses in excess of $3M
Other Benefits:
accelerated write-offs, timing on utilization of expenditures, unused credits carry forward
Provincial Credits also available
Source & more info at:

18. You and Your Employees Will Love Living Here
Dynamic Metro Region
You and Your Employees Will Love Living Here
#1 Best Place to Live Cities Ranking, January
(Safety, liveability, cost of living, business environment, democracy and food security)
Source:

19. 10 YEARS TO BUILD MOMENTUM CAN NOW DEMONSTRATE OPPORTUNITIES
WHY NOW?
10 YEARS TO BUILD MOMENTUM
CAN NOW DEMONSTRATE OPPORTUNITIES

20. WE ALL BENEFIT Suppliers & Services Companies Organizations
Pharmaceuticals/ Biologics
Research/Skills Development Organizations
Specialized Business Services
Medical Devices
Innovation Organizations
Specialized Risk Capital
Industry Associations
Health Care IT
Healthcare Delivery Organizations
Private Payers
Contract Research/Mfg
Government
Patient Advocates

21. HOW WE ALL BUILD MOMENTUM
DOWLOAD AND USE THE BRANDING AND NARRATIVE IN PRESENTATIONS INTERNALLY AND EXPERNALLY
CONNECT WITH US ON SOCIAL MEDIA
SHARE GOOD NEWS STORIES WIDELY
BECOME A SPONSOR TO SHAPE THE PROGRAM

22. Engaged Human health cluster committee
Pharmaceuticals/Biologics
Elaine Campbell, Co-chair, Past President, AstraZeneca Canada
Mark Lievonen, President, Sanofi Pasteur Limited
Ghislain Boudreau, Vice President, Public Affairs, Pfizer Canada
Thomas P. Reeves, President, Interface Biologics
Research Hospitals
Barry McLellan, Co-chair, President and CEO, Sunnybrook Health Sciences Centre
Innovation Organizations
Ilse Treurnicht, CEO, MaRS Discovery District
Zayna Khayat, Senior Advisor Health System Innovation, MaRS Discovery District
Susan Marlin, President & CEO, Clinical Trials Ontario
Michael May, CEO, Centre for Commercialization of Regenerative Medicine
Specialized Business Services
Paola Cipolla, Audit Leader, Biotechnology Industry, GTA KPMG
Medical Technology/Digital Health
Neil Fraser, President & Regional Vice President, Medtronic of Canada Ltd.
Frank Florio, President, BD Canada
Paul Lepage, President, Telus Health
Health Care Delivery
Sue Paish, President & CEO, LifeLabs
Universities & Colleges
Peter Lewis, Interim Vice President – Research, University of Toronto
Finance
Benjamin Rovinski, Managing Director, Lumira Capital
Stefan Larson, Executive-in-Residence, Versant Ventures
Facilitating Partner
Janet De Silva, CEO Toronto Region Board of Trade
Briefing Document

23. TO Health! 3 year plan of action

24. Proposed governance model
Industry led TO Health! is an industry led private-public partnership. Going forward, the Human Health & Sciences committee will consist of executives from sponsor organizations determining strategy and directing activities of the initiative. Economic development TO Health! is a cluster initiative, which fits into an economic development mandate for the Toronto region. Going forward, we will continue seeking further support from the City of Toronto, other municipalities and the new regional economic development organization. Funding TO Health! will be funded through a variety of sources including private industry sponsorship and in-kind contributions from key stakeholders, government support and brand ambassadors.
Briefing Document

25. Come discover the action
Talent
Investors
Business
Be at the centre of over $1 billion in annual research spending, global calibre of basic and translational research, vibrant clinical research networks and a thriving independent clinical research community
Live big in a large, cosmopolitan and diverse mega-city with a quality of life friendly to families and young professionals
Tap into strong, geographically concentrated network of universities/colleges, 9 research hospitals, established companies and vibrant start-ups
Discover a target rich environment for a diverse health investment portfolio at attractive valuations
Assess centralized health data and large diverse pool of potential clinical trial patients, who are more motivated and educated than many other groups, including the U.S.
Take advantage of a lower cost business environment, generous tax incentives and government support
Briefing Document

26. Want to learn more?
Contact us at:
tohealth.ca
@TOHealthToronto